The steroid hormones and bile acids are important to digestive tract structure and function. Glucocorticoids administered during pregnancy have been shown to induce cleft palate in the offspring in several species. Postnatally, a significant rise in corticosterone during week 3 in the rat coincides with profound morphological and biochemical changes in the small intestine toward the adult state. Exogenous glucocorticoids given suckling rats leads to precocious development of these changes. In the adult, glucocorticoids increase brush border enzyme levels, while adrenal insufficiency decreases mucosal weight, enzyme activity, and absorptive functions. Water and sodium absorption and potassium excretion are enhanced in both small and large intestine. The jejunum, through its sense of food, provides the entraining signal that governs conicosterone rhythm. In the stomach, high doses of glucocorticoids inhibit prostaglandin biosynthesis, thereby inhibiting the gastric alkaline response and producing severe gastric lesions. However, in man, peptic ulcer disease is not clearly associated with glucocorticoid therapy. Exacerbation of subclinical intestinal infections and perforative lesions have been observed in both animals and man given glucocorticoids. The female sex hormone estrogen, when given to rats, stimulates intestinal enzyme levels and facilitates absorption. Progesterone inhibits both circular and longitudinal smooth muscle contractile activity. Virtually the entire pool of bile acids is found in the enterohepatic circulation. The dihydroxy secondary bile acids, regardless of their conjugation states, are physiologically and morphologically more damaging to mucosal cell membranes than are the trihydroxy primary bile acids. * Presented at the Sixth International Symposium of the Society of Toxicologic Pathologists: "Gastrointestinal Toxicologic Pathology." June 1-3, 1987 in Philadelphia, Pennsylvania.
INTRODUCTION
Three major classes of steroids pass through the gastrointestinal tract: cholesterol (endogenous or dietary), bile acids, and steroid hormones synthesized by the adrenal cortex and gonads. The steroid hormones include the C2, corticosteroids, C,, progestational hormones, C,, androgens, and C18 estrogens (Fig. 1) . The purpose of this paper is to review the effects of glucocorticoids, sex hormones, and bile acids on the structure and function of the alimentary tract and, where possible, to relate their activity to disease in this system. Most of the paper will discuss the glucocorticoids.
CLEFT PALATE INDUCED BY GLUCOCORTICOIDS In 195 1, Frazer and Fainstat dosed two strains of pregnant mice with cortisone at doses of from 0.625 to 10 mg/day to study the effects ofcortisone on the development of cleft palate (22) . When treatment (1.25 BL embryos, and partly to the lesser inhibition of shelf movement in the C57 BL embryos as compared to A/Jax embryos.
To further compare the effects of more than one corticoid as well as the effects of the route of administration upon the induction of cleft palate in the same protocol, Blaustein et a1 (7) dosed pregnant CD-1 mice on days 1 1 to 14 either intramuscularly, interperitoneally, or subcutaneously with cortisone, hydrocortisone, corticosterone, ACTH, epinephrine, or the vehicle solution. The glucocorticoids were given at 2.5 mglanimal. The study demonstrated that cortisone and hydrocortisone significantly increased cleft palate frequency by all three injection routes, while corticosterone increased the frequency only when given by the intramuscular and subcutaneous routes. Walker (8 1) demonstrated that triamcinolone acetonide given intramuscularly to A/J strain pregnant mice on days 11 to 14 at doses of from 0.0 125 to 0.00 1 mglday caused cleft palates, with frequencies ranging from 100 down to 18%. Triamcinolone produced cleft palates in mouse embryos at a dosage proportionate, by body weight, to the common therapeutic dosage for humans. Widely ranging doses of desoxycorticosterone did not produce cleft palates.
In 1967, Walker reported that some glucocorticoids (triamcinolone, dexamethasone, prednisolone) produced cleft palates in rabbits, but others (cortisone, betamethasone, methylprednisolone) showed very weak or lacked teratogenic potential (82) .
Studies on the effect of glucocorticoids administered ophthalmically to pregnant mice during days 10 to 13 of gestation demonstrated that hydrocortisone succinate induced cleft palate formation in 52.8% and 72.2% of fetuses when dams were dosed at 1,500 and 3,000 mg/animal/day (2) . These results were consistent with an earlier report that ophthalmically applied dexamethasone induced cleft palates in rabbits (73) . DEVELOPMENT OF THE GASTRIC MLJCOSA  Studies on the effects ofexogenous glucocorticoids  on the development of the stomach have demonstrated precocious development of pepsinogen (23, 76) and of gastrin receptors and antral gastrin levels (52) . Adrenalectomy delayed the rise of both gastrin receptors and antral gastrin levels in the stomach. The effect of corticosterone on the growth of the gastric mucosa during development was studied by Tseng and Johnson (80) . Corticosterone administration during the first and second postnatal weeks induced the precocious appearance of pepsinogen in the oxyntic gland mucosa and increased basal acid output (Figs. 2, 3 ). The data confirmed that during the first and second postnatal weeks, corticosterone induced the precocious development of chief cells. These effects disappeared by day 25. The data also suggested that corticosterone induced the precocious maturation of the parietal cells. Daily injections ofcorticosterone enhanced basal acid secretion in a dose-related manner. When maximal acid output was measured by day 20 after pups were injected with histamine, acid output was higher in corticosterone-treated than in control animals.
EFFECTS OF GLUCOCORTICOIDS UPON THE

EFFECTS OF GLUCOCORTICOIDS UPON THE DEVELOPING SMALL INTESTINE
During maturation, the suckling rat intestine has been demonstrated to have a glucocorticoid-sensitive period during the third week of life (29) . Maturation of intestinal sucrase and maltase appears to be dependent on a physiologic rise in plasma corticosterone level, which occurs on day 14 of life (28) . The concentration of total corticosterone in rat plasma shows the developmental pattern ( Fig. 4 ). It is less than 0.5 mudl from day 6 through day 12, but reaches 5 mg/dl on day 17. A rise in plasma corticosteroids during this critical developmental period has also been demonstrated in the rabbit (41) .
During the third week of postnatal life in the rat, profound morphological and biochemical changes occur in the small intestine. These include increases in intestinal weight, villus and crypt height, cell migration rate, thymidine kinase levels, and RNA and DNA content (1 9. The enhanced cell proliferation leads to mucosal hyperplasia, which develops equally throughout the entire small intestine (12) . Intestinal enzymatic activity also undergoes rapid adaptation between days 14 and 2 1. All these intestinal changes are in the direction ofadult values; in many cases they overshoot adult values.
There is considerable evidence that the administration of glucocorticoids to the suckling rat will either induce the precocious appearance of, or increase, a-glucosidases (8), jejunal sucrase, intestinal invertase (20) , ileal bile' salt transport (37), pinocytosis (32) , and the uptake of immunoglobulins (5 1). Conversely, adrenalectomy of the suckling rat will prevent the occurrence of maturational events at the appropriate time.
Moog (43) summarized the literature on the effects of glucocorticoids on properties of the intestinal epithelium of suckling rats and mice. There is a precocious elevation of alkaline phosphatase activity, premature closure to macromolecules, an increase in the number of goblet cells, precocious appearance of sucrase activity, cessation of B,2 absorption independent of intrinsic factor, an early increase of leucyl naphthylamidase activity, and an 850% increase in maltase synthesis. Buts and DeMeyer (1 1) demonstrated that low doses of steroid given to the suckling rat failed to enhance the intestinal synthesis of enzymes and produced significant decreases in intestinal protein. In the jejunum as well as the ileum, the incorporation rates of [,HI thymidine into DNA were reduced to a level of about 70% that of the controls. Higher doses of hydrocortisone had a marked suppressive effect on DNA synthesis in the jejunum and ileum, the values in the steroid-treated group being about one-half those of the control group.
Adrenocortical secretions have also been implicated as regulators of developmental changes in the fetal guinea pig duodenum (44) . Cortisone accelerated villus maturation, including the formation of previllous ridges (on days 1 1 and 13), elongation of villi (on day 15), vascularization of villi (on days 17 and 19), and increased epithelial cell height (on day 19) . Cortisone exposure induced alkaline phosphatase activity in 13-and 15-day chick duodena and promoted phosphatase activity in 17-and 19-day explanted duodena (26, 27) . Further studies in this system demonstrated that hydrocortisone inhibited the premature differentiation of goblet cells induced by thyroxine and lowered mitotic counts, as compared to control cultures at 24 hours, with a plateau between 48 and 72 hours of culture. At 72 hours, the mitotic index was higher in cultures given hydrocortisone than it was in in vifro control duodena.
Organ culture of the embryonic chick duodenum has also been used to study the development and function of the vitamin D-dependent calcium absorptive mechanism (1 7, SO), and to study the control of duodenal development by glucocorticoids and thyroid hormone. In this system, glucocorticoids have been shown to augment calcium binding protein induction by vitamin D, and by an active metabolite, 1,25-dihyroxyvitamin D, (1 ,25(OH),D3). Dexamethasone increased 1 ,25(OH)2D3 receptor retention in the nucleus in the embryonic chick duodenum (1 8) . Calcium binding protein, as a function of tissue weight, was 50% greater in hydrocortisonesti-mulated intestine versus control, but the proliferogenic action d' f hydrocortisone on the duodenum alone could not account for the glucocorticoid-1 ,25(OH2)D3 interaction in calcium binding protein synthesis (9) .
Emms OF GLUCOCORTICOIDS ON THE MATURE INTESTINE The finding of glucocorticoid receptors in intes-
tinal mucosal cells suggests that glucocorticoids per se play a role in the normal function of the small BLACK TOXICOLOGIC PATHOLOGY intestine (54) . Glucocorticoids act principally by binding to specific cytoplasmic receptor proteins which are present in the enterocyte (54, 88) . The activated steroid and receptor complex is then rapidly translocated to the nucleus, where binding to protein occurs. Template activity is enhanced and specific messenger RNAs for inducible enzymes are produced, thus leading to enhanced enzyme synthesis. In the rat intestine, prednisolone significantly increases RNA associated with the rough endoplasmic reticulum, that is membrane bound ribosomes and associated RNA, and significantly increases 14Ctyrosine labelling of brush border proteins (3). Increased brush border enzyme activity and hexose absorption have been demonstrated in the rat small intestine in response to glucocorticoid administration (1, 4) . Oral prednisolone administered for 1 week or 1 month selectively enhanced brush border a-glucosidase and leucyl-2-naphthylamidase activity and increased D-galactose absorption in the jejunum and ileum of the normal rat (4, 62, 63) . Studies with adrenalectomized rats have not clarified further the role of glucocorticoids in the small intestine. It has been observed, however, that adrenal insufficiency causes a reduction in small intestinal mucosal weight, with decreased brush border enzyme activity, reduced hexose, amino acid, salt and water absorption, and decreased postabsorptive mucosal esteriiication of fatty acids (36, 74) .
Studies in rats that have had their jejunum resected demonstrated that rats given prednisolone, when compared to resected controls, had selectively enhanced brush border digestive capacity without a further increase in cell proliferation. The increase was the result of a selective increase in the activity of the brush border digestive enzymes of the enterocytes, and-not of lysosomal or mitochondria1 enzymes or total enterocyte protein. An increase in enterocyte RNA suggested that enzyme induction may have been the mechanism of this effect (61) . The normal adaptive response to resection is a large increase in the number of absorptive cells, small bowel dilation, villous hypertrophy, more rapid cell migration, and enhanced digestive enzyme activity and absorption (85, 86) . Thus, prednisolone added a functional hypertrophy to a normal adaptive hyperplasia.
It2 v i m studies of cultured human jejunum have demonstrated that hydrocortisone increased the activity of brush border alkaline phosphatase (Fig. 5) , a-glucosidase, leucyl-2-naphthylamidase, and cytoplasmic-mitochondria1 malate dehydrogenase. Uptake of glucose was increased. Labelling of protein with L-[14C] tyrosine and glycoprotein with D-[3H] glucosamine was also increased. Inhibitors of glucocorticoid receptor binding (progesterone), mRNA transcription (a-amanitin), and protein synthesis (cycloheximide) prevented the effect of hydrocortisone (64) .
Glucocorticoids given to adult rats as methylprednisolone, 30 mg/kg body weight for 3 days, resulted in significant enhancement of water and sodium absorption and potassium secretion in segments of small and large intestine (65) . These changes in transport were associated with an increase in potential differences and Na+K+-ATPase activity in all intestinal segments (14) . A second glucocorticoid, dexamethasone, given parenterally for 3 days, increased water and sodium absorption and potassium secretion in the adult rat colon. Potential difference and Na+K+-ATPase activity were again increased. There was an increasing colonic response with increasing dexamethasone dosage. Changes were initiated within 3 hours of steroid administration and persisted for 24 hours. The colon was sensitive to very low doses of dexamethasone (6) .
EFFEC~S OF THE JEJUNUM ON
PLASMA CORTICOSTERONE LEVELS Circadian rhythmicity of adrenocortical activity has been well recognized in human subjects and laboratory animals. In rats, the phase of the rhythmic changes in blood corticosterone concentration shifts when feeding time is changed, regardless of the lighting condition. It takes about 10 days to establish a corticosterone rhythm corresponding to a new cycle, but once it is found, it persists even during starvation. Kato et a1 (33) demonstrated in rats that a normal corticosterone rhythm was retained when either jejunal or ileal resections were performed. Jejunal resection, however, resulted in a significantly lower amplitude in the rhythm compared to the ileal resection. Thus it would appear that thejejunum is an important site where the sense of food is received as an entraining signal for the corticosterone rhythm.
CORTICOSTEROIDS AND GASTRIC LESIONS Prednisolone has been reported to produce gastric lesions as its untpward effect in experimental animals and man (31, 58) . This agent is known to inhibit the biosynthesis of endogenous prostaglandins by preventing liberation of arachidonic acids from membrane phospholipids in various organs (25, 35) .
Robert et a1 (59, 60) suggested that endogenous prostaglandins may be necessary for the maintenance of the cellular integrity of the gastric mucosa. Since prostaglandins have such diverse actions as increasing mucosal blood flow, mucous secretion, and cell proliferative activity (5, 34, 40) , changes in these factors, together with the alkaline response, may contribute to the pathogenesis of the steroidinduced lesion.
Recent studies have shown that the gastric alkaline response (a diffusion of HCOJ occurs in the stomach exposed to mucosal damaging agents, and plays an important role in the repair process of the damaged mucosa (72, 75) . Further, a local production of endogenous prostaglandins has been shown to be involved in the regulation of this phenomenon by inhibiting acid secretion (47, 71) . Studies in the rat have shown, however, that prednisolone inhibited the gastric alkaline response when 1 M NaCl was administered, reduced generation of endogenous prostaglandins, and induced severe gastric lesions (Figs. 6,7) (48). In another study, when prednisolone was given to rats at 50 mg/kg once daily for more than 2 days, gastric lesions were produced in the normal fed animals. However, since the administration of 16,16-dm PGE, prevented formation of intestinal lesions in response to prolonged treatment with prednisolone (35, 57), a deficiency of endogenous prostaglandins would appear to have been involved in the pathogenesis of the gastric lesions.
Some epidemiologic data have suggested that therapy with large doses of prednisolone may lead to ulceration in some patients (15, 16) . However data on the relationship between corticosteroids and peptic ulceration have been derived largely from retrospective and prospective studies ofpatients with rheumatoid arthritis and other chronic diseases. A review of the literature by Conn and Blitzer (15) included 82 double-blind and 18 other trials, for a total of 6,102 patients. These investigators concluded that there was no clear association between adrenocorticosteroid treatment and peptic ulcer, with the exception of patients with cirrhosis or chronic renal failure. Hypoalbuminemia in these patients may have resulted in higher blood levels ofunbound steroid, which consequently had an ulcerogenic effect. 
GLUCOCORTICOID ADMINISTRATION AND
UNDERLYING D~SWE The administration of corticosteroids to expenmental animals or man in the presence ofunderlying disease or stressful situations may lead to serious adverse results. The beneficial effects of corticosteroids in the veterinary neurosurgical patient is well documented; however, infrequently, postoperative gastrointestinal complications result in the patient's death (30, 78, 79) . Sorjouen et a1 (69) reported that gastrointestinal disease developed in 50 of 257 consecutive dogs with spinal cord injury after large-dose corticosteroid therapy and thoracolumbar hemilaminectomy. Anorexia, palpable abdominal pain, vomiting, and dark-colored diarrhea were the most common clinical signs of gastrointestinal disease. In dogs which died, dexamethasone had produced acute 
BLACK
TOXICOLOGIC PATHOLOGY reddening of the gastric mucosa with frank hemorrhage, digested blood, and possible gastric erosions.
Corticosteroid-associated colonic perforation has been frequently reported in man (13, 53, 77, 84) . Mortality rates associated with intestinal perforation in human patients receiving steroids range from 27% to 100% (55). Due to the anti-inflammatory effects of corticosteroid therapy, the systemic reaction and physical signs associated with a perforated viscus are often masked until late in the course of  disease (70,77) . Mortality is extremely high (1 3,53,  77, 84) . Inhibition of the inflammatory response, inhibition of fibroblast proliferation, increased collagen breakdown, and immunosuppression in corticosteroid-treated patients may lead to a decreased ability to wall off a perforative lesion, and consequently may lead to a greater frequency of gross fecal contamination. Generalized peritonitis, reduced peritoneal protective response to soilage, and a greater frequency ofgram-negative septicemia ensue (77, 83).
Steroids have had beneficial effects on the clinical course of ulcerative colitis (42). However, because of the potential side effects of prolonged treatment, this treatment is reserved for use in patients who have proven to be refractory to other forms of therapy. Colectomy and ileostomy have been employed as the final therapeutic step. Morbidity related to severe wound infections, intra-abdominal abscesses, septicemia, wound dehiscence, retraction of mucous fistulas, severe electrolyte imbalance, hemorrhage, convulsions, and psychosis are all increased in patients who have been given corticosteroids prior to surgery.
The influence of corticosteroids on the initiation or aggravation of infections has been described in detail (66, 68). In addition to bacterial, viral, rickettsia], or fungal infections (38,45,66) , there is clinical and experimental evidence that some protozoan diseases, such as trypanosomiasis, malaria, and amebiasis, may be aggravated by steroid therapy (21, 87) . In humans, Cruz et a1 (19) reported fatal cases of strongyloidiasis in association with corticosteroid therapy used for other conditions. It was suggested that the effect of the corticoids of suppressing the inflammatory and immunologic response, may have altered the host-parasite equilibrium, and may thus have played an important role in the sudden occurrence of severe strongyloidiasis.
Disseminated candidiasis dramatically increases in immunosuppressed patients. The most important factors that predispose a patient to disseminated candidiasis include the use of broad spectrum antibiotics, adrenal corticosteroid therapy, and severe granulocytopenia (46). Gastrointestinal coloniza-tion by candida yeasts in immunosuppressed patients is aided by the use of antibiotics. Histoinvasive lesions most commonly develop in the distal esophagus. Submucosal invasion gives the organism access to blood vessels which, upon invasion, allows hematogenous dissemination to numerous organs. Experimentally, immunosuppressed rats have been shown to develop hematogenous dissemination of candida in 25% of animals following oral feeding of Candida albicans when cortisone acetate was added to the regimen, versus only 10% dissemination in animals which did not receive the corticoid (45).
EFFECTS OF SEX STEROIDS UPON THE
GASTROINTESTINAL T R A~ There appears to be a relationship between sex hormones and intestinal functions. Singh et a1 (67) cited studies which demonstrated that rates ofwater and glucose absorption were higher in female than male rats, that ovariectomy might impair the intestinal absorption of glucose, that sex differences exist in the activity of certain digestive enzymes, and that synthetic steroidal contraceptives can influence intestinal digestive and absorptive functions. The studies by Singh et a1 demonstrated that 17B-estradiol enhanced the ilia1 activity of disaccharidases and leucine aminopeptidase alone or in combination with progesterone, whereas in the jejunum only alkaline phosphatase activity was increased significantly. Only 17p-estradiol appeared to play an important role in regulating intestinal digestive enzymes, and only the ileal enzymes appeared to be modulated.
The sex hormones have also been shown to have an effect upon the contractile characteristics of the intestinal tract. Bruce and Behsudi (10) demonstrated that tissues taken from rats pretreated with progesterone had a marked reduction in contractile activity, compared to tissues taken from pair controls not given progesterone. The percentage of inhibition seen with in vivo progesterone pretreatment on irz vifro esophageal, antral, and colonic tissue activity was 68.7, 67.3, and 53.1, respectively, compared to the corresponding nontreated regional tissue responses. Gill et al (24) demonstrated that progesterone had a dose-dependent inhibitory effect upon the'contractile acfivity of both longitudinal and circular smooth muscle layers of the canine colon ( Fig.  8) . Although these authors did not precisely elucidate the mechanism by which progesterone induced its inhibitory activity, their results were consistent with the concept that progesterone acted either on the cell membrane or at the intracellular level to modulate cytoplasmic calcium concentrations. These findings may help to explain the reduced colonic activity resulting in varying degrees of constipation, which is a general complaint that occurs during pregnancy.
BILE ACIDS AND THE GASTROINTESTINAL TRACT
Three major classes of. steroids include (1) cholesterol originating from the diet, liver, intestinal epithelium, and other tissues; (2) bile acids synthesized from cholesterol in the liver and excreted via the biliary tract; and (3) steroid hormones synthesized from cholesterol in the adrenal cortex and gonads, cleared by the liver, and excreted via the biliary tract. Roughly 400-1,000 mg of cholesterol, 100-500 mg of bile acids, and less than 2 mg of steroid hormones pass daily through the colon of a healthy nonpregnant human. Cholesterol and steroid hormones are generally water insoluble. Bile acids occur in both monomeric and micellar forms, and are generally ionized (39) .
In a healthy fasting man, virtually the entire bile acid pool, about 2 g, is found in the enterohepatic circulation. More than 97% of bile acids are actively reabsorbed in the distal ileum and returned to the liver via the portal veins. The remaining bile acids pass into the large intestine, where they undergo extensive bacterial degradation. The degradation products and some unchanged bile acids are largely excreted in the feces, but a certain proportion is absorbed from the colon and returned to the liver.
Like the bile acids, neutral and phenolic steroids can undergo enterohepatic circulation. Differences in chemical structure, such as an extra hydroxyl group or the shape of the molecule, can influence the excretion route of the steroids. It is believed that a molecular weight of 300-600 is required for enterohepatic circulation, which is precisely the range of the conjugated compounds. The steroids are conjugated in the liver with sulfonic or glucuronic acid, the type of conjugation being determined by the chemical structure of the steroid.
The detergent action of bile salts in the stomach can result in the breakdown of gastric mucosal permeability. This may be preceded by an inhibition of active absorptive Na+ transport. In the presence of conjugated taurocholate or unconjugated deoxycholate at high (7.4) or low (3.4) mucosal pH, only unconjugated deoxycholate will inhibit active Na+ transport from mucosa to submucosa. Inhibition of Na+ transport is apparent at a low level of deoxycholate (49) .
Compared to the trihydroxy primary bile acids, the dihydroxy secondary bile acids, regardless of conjugation status, are physiologically and morphologically more damaging to the intestinal mucosa and to hepatocyte, lymphocyte, and erythrocyte cell membranes. Studies by Ritchie and Felger (56) demonstrated that in both ischemic and nonischemic gastric mucosa of the dog the dihydroxy secondary bile acids induced a more profound increase in mucosal permeability to hydrogen ion. In ischemic mucosa, they induced a more severe degree of gross mucosal damage than did the trihydroxy primary bile acids. It was suggested that the effects may be related to a greater lipid solubility and consequent capacity to disrupt cell membranes. The data suggested these bile acids "solubilize" only the outer layer of the lipid bilayer of the cell wall. In contrast, the deconjugated secondary bile acid, deoxycholic, removed considerably more protein, membrane bound enzymes, and phospholipid from the cell, and included complete cellular dissolution. Deoxycholic acid has also been shown to be more damaging to rat hepatocyte membranes than either the primary bile acid, cholic, or its conjugates, taurocholic and glycocholic acids. The dihydroxy bile acids, both conjugated and deconjugated, also inhibit rat colonic Mg++ and Na+K+-ATPase to a significantly greater degree than do other bile acid moieties.
The effects of dihydroxy, secondary, and free bile acids on colonic and small bowel mucosa indicate that the conjugated and deconjugated dihydroxy secondary bile acids, and, to a lesser degree, the deconjugated dihydroxy primary bile acids, are physiologically and morphologically more damaging to the mucos'a of the distal small bowel and colon than are the conjugated and deconjugated trihydroxy primary bile acids (56) .
